IGFBP-3, the most abundant IGFBP in circulation, binds a majority of the circulating IGF-1 in complex with ALS, thereby prolonging IGF-1’s half-life and enhancing its biological effects [9]. The gene discussed is IGF1; the disease is amyotrophic lateral sclerosis.